Login / Signup

Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trials.

Diane St GermainAndrea DenicoffAndrea D TorresJoseph KelaghanWorta McCaskill-StevensGrace MishkinAnn O'MaraLori M Minasian
Published in: Cancer (2020)
The results of the current study demonstrated that approximately 45% of the PT publications were followed by a HRQOL publication within 1 year, to allow the knowledge to be used in patient treatment decision making. The authors believe the current analysis is an important first step toward a better understand of the challenges that researchers face when reporting HRQOL endpoints.
Keyphrases
  • decision making
  • adverse drug
  • healthcare
  • emergency department
  • combination therapy
  • electronic health record
  • replacement therapy